Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Renovaro Inc

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
From Renovaro Inc
Via GlobeNewswire
Tickers POAI RENB
Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
From Renovaro Inc
Via GlobeNewswire
Tickers POAI RENB
Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
From Renovaro Inc
Via GlobeNewswire
Tickers POAI RENB
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
From Renovaro Inc
Via GlobeNewswire
Tickers POAI RENB
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
Renovaro Announces $15 million in Equity Committed
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
Renovaro Appoints Nathen Fuentes as Chief Financial Officer
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
Renovaro Issues Shareholder Letter and Provides Corporate Update
From Renovaro Inc
Via GlobeNewswire
Tickers POAI RENB
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
From Renovaro Inc
Via GlobeNewswire
Tickers POAI RENB
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
Renovaro Regains Compliance with NASDAQ Listing Requirement
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
Renovaro Issues Shareholder Letter and Provides Corporate Update
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
Renovaro Announces Strategic Restructuring and Leadership Transition
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
RenovaroCube Announces Strategic Offering of Up to 20% Ownership
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
Renovaro, Inc. Announces $10 million in Equity Committed
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
From Renovaro Inc
Via GlobeNewswire
Tickers RENB
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.